A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety Genexol-PM(CrEL-free polymeric micelle formulated
paclitaxel)and gemcitabine in untreated metastatic NSCLC patients